Skip to main content
OpenTrials

Clinical trial condition

Cytopenia

Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.

1,012 public trials 192 recruiting studies
Refine in advanced search Browse all conditions

Cytopenia trial results

Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View Trial Details
Recruiting

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

NCT06929299

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • North China University of Science and Technology Affiliated Hospital Tangshan, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 21 locations
View Trial Details
Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

NCT07104565

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Palo Verde Cancer Specialists Palo Verde Hematology Oncology, Ltd Glendale Glendale, Arizona, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 40 locations
View Trial Details
Recruiting

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

NCT07059000

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California Los Angeles, California, United States
  • NY Cancer and Blood Specialists Shirley, New York, United States
  • East Carolina University Greenville, North Carolina, United States
  • Vseobecna Fakultni Nemocnice v Praze Prague, Czechia
View all 28 locations
View Trial Details
Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

NCT06056297

Conditions
Abnormalities, Multiple, Agranulocytosis, Autoimmune Diseases, +31 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UC Irvine Irvine, California, United States
  • Orso Health La Jolla, California, United States
  • University of California, Los Angeles-UCLA Los Angeles, California, United States
View all 114 locations
View Trial Details

Related conditions